Skip to content

The Beauty Health Company SKIN FX & Other Adjustments

FX & Other Adjustments at other companies

eXp World Holdings, Inc. Common Stock logo
eXp World Holdings, Inc. Common StockAGNT
$161.5K+158%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
-$809K-196%
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
$8.42M+145%
RDI
Reading International, Inc.RDI
$215K+36.1%
MAG
MagneraMAGN
$750K+200%
Scansource logo
ScansourceSCSC
$657K-22.7%

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's fx & other adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's FX & other adjustments?
The Beauty Health Company (SKIN) reported FX & other adjustments of -$375K in Q1 2026.
How has The Beauty Health Company's FX & other adjustments changed year-over-year?
The Beauty Health Company's FX & other adjustments decreased by 149.3% year-over-year, from $761K to -$375K.
What does FX & other adjustments mean?
Captures the impact of fluctuations in foreign exchange rates on the valuation of assets and liabilities denominated in currencies other than the reporting currency. It reflects the company's exposure to international market volatility and currency risk.